TTrialPathMatch Me to Trials
← Back to trials
RecruitingObstructive Sleep Apnea of AdultPreeclampsiaObstetrical Complications

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Eligible age

18+ yrs

Accepts

Women

Locations

10 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate of hypertensive disorders of pregnancy.

Sponsor: The George Washington University Biostatistics Center

You may qualify if…

  • 1. Singleton gestation. Twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age.
  • 2. Gestational age at randomization between 14 weeks 0 days and 21 weeks 6 days based on clinical information and evaluation of the earliest ultrasound.
  • 3. Diagnosis with mild to moderate OSA as defined by an AHI score ≥ 5 and \<30.

You may not qualify if…

  • 1. Previously prescribed, current or planned therapy for sleep apnea.
  • 2. Age \< 18 years, because the rate of sleep apnea in this population is extremely low.
  • 3. Inability to sleep in a stable place with access to the CPAP machine at least 5 nights per week.
  • 4. Asthma requiring systemic steroid therapy for more than 14 days within the past 6 months because this population is expected to be unresponsive to CPAP therapy.
  • 5. Current use of prescribed sleeping pills for insomnia.
  • 6. Chronic medical conditions requiring oxygen supplementation (e.g. pulmonary fibrosis, pulmonary hypertension, cystic fibrosis) because this population is expected to be unresponsive to CPAP therapy.
  • 7. Chronic renal disease with serum creatinine \>1.3 mg/dL because the primary outcome would be pre-determined.
  • 8. Antiphospholipid antibody syndrome, because it would compromise the primary outcome diagnosis.

Where it's recruiting

Alabama

Birmingham

California

San Francisco

Illinois

Chicago

New York

New York

North Carolina

Chapel Hill

Ohio

Cleveland · Columbus

Pennsylvania

Philadelphia · Pittsburgh

Rhode Island

Providence

Texas

Galveston · Houston

Utah

Salt Lake City

Source: ClinicalTrials.gov · NCT03487185 · last updated 2026-04-06